Back to search

Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

Data up to Jan 2025

Published1994
Citations1,428
References60

Total Citations Per Year

Abstract

References (60)

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Regression Models and Life-Tables

1992 • 27,454 citations

Regression Models and Life-Tables

1972 • 27,145 citations

Statistical Methods for Rates and Proportions

2003 • 17,930 citations

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

1977 • 8,468 citations

Nonparametric Estimation from Incomplete Observations

1958 • 7,673 citations

Proposals for the Classification of the Acute Leukaemias F<scp>rench</scp>‐A<scp>merican</scp>‐B<scp>ritish</scp> (FAB) C<scp>o‐operative</scp> G<scp>roup</scp>

1976 • 5,620 citations

Statistical Methods for Rates and Proportions, 2nd ed

1981 • 3,735 citations

Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia

1985 • 2,981 citations

Bone marrow transplant

1999 • 2,452 citations

EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA.

1964 • 763 citations

Criteria for the Diagnosis of Acute Leukemia of Megakaryocyte Lineage (M7)

1985 • 752 citations

Arabinosyl Cytosine: A Useful Agent in the Treatment of Acute Leukemia in Adults

1968 • 559 citations

Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens [see comments]

1990 • 525 citations

Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous Leukemia

1995 • 458 citations

Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B

1981 • 451 citations

Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens [see comments]

1990 • 446 citations

Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B

1981 • 395 citations

Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group.

1985 • 366 citations

PRINCIPAL RESULTS OF THE MEDICAL RESEARCH COUNCIL'S 8th ACUTE MYELOID LEUKAEMIA TRIAL

1986 • 329 citations

Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B study

1987 • 305 citations

Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update

1983 • 279 citations

Varying intensity of postremission therapy in acute myeloid leukemia

1992 • 272 citations

Cytarabine and neurologic toxicity.

1991 • 264 citations

Varying intensity of postremission therapy in acute myeloid leukemia

1992 • 228 citations

High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results.

1989 • 149 citations

Failure of remission induction in acute myelocytic leukemia

1978 • 148 citations

Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT).

1991 • 135 citations

ACUTE MYELOGENOUS LEUKAEMIA: MAINTENANCE CHEMOTHERAPY AFTER EARLY CONSOLIDATION TREATMENT DOES NOT PROLONG SURVIVAL

1984 • 119 citations

A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeastern Cancer Study Group trial

1984 • 108 citations

Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia

1992 • 99 citations

Intensive remission consolidation therapy in the treatment of acute nonlymphocytic leukemia.

1987 • 95 citations

Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia.

1992 • 93 citations

Current chemotherapeutic treatment approaches to the management of previously untreated adults with de novo acute myelogenous leukemia.

1987 • 91 citations

High dose cytarabine: a review.

1988 • 77 citations

Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission.

1992 • 76 citations

T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission

1992 • 73 citations

Acute nonlymphoblastic leukemia. Prognostic factors in adults with long-term follow-up

1982 • 72 citations

T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission

1992 • 72 citations

Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group B.

1987 • 69 citations

Distribution of 250 Cases of Acute Myeloid Leukaemia (AML) according to the FAB Classification and Response to Therapy

1981 • 62 citations

The role of intensive postinduction chemotherapy in the management of patients with acute myelogenous leukemia.

1982 • 58 citations

Long-term disease-free survival in acute nonlymphocytic leukemia

1981 • 56 citations

Long term survival in acute myeloid leukemia: The eastern cooperative oncology group (ECOG) experience

1991 • 53 citations

Progress report from the International Bone Marrow Transplant Registry.

1992 • 53 citations

The heritable nature of clonal characteristics in acute myeloblastic leukemia

1981 • 52 citations

Reasons That Patients with Acute Myelogenous Leukemia Do Not Undergo Allogeneic Bone Marrow Transplantation

1992 • 50 citations

CHEMOTHERAPY VERSUS TRANSPLANTATION IN ACUTE LEUKAEMIA

1989 • 46 citations

1993 progress report from the International Bone Marrow Transplant Registry. Advisory Committee of the International Bone Marrow Transplant Registry.

1993 • 42 citations

The role of intensive remission induction and consolidation therapy in patients with acute myeloid leukaemia

1987 • 42 citations

Does stem cell exhaustion result from combining hematopoietic growth factors with chemotherapy? If so, how do we prevent it? [editorial; comment]

1992 • 42 citations

Double intensive consolidation chemotherapy in adult acute myeloid leukemia.

1991 • 39 citations

Allogeneic transplantation versus intensive chemotherapy in first-remission acute leukemia: is there a "best choice"?

1988 • 38 citations

Diagnostic concurrence in the subclassification of adult acute leukemia using French-American-British criteria

1982 • 35 citations

The Approach to the Elderly Patient with Acute Myeloid Leukemia

1993 • 34 citations

ACUTE MYELOID LEUKAEMIA: IS ‘CONSOLIDATION’THERAPY NECESSARY?

1984 • 16 citations

Early intensification and short-term maintenance chemotherapy does not prolong survival in acute myelogenous leukemia

1986 • 15 citations

A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B

1993 • 14 citations

In adult acute nonlymphoblastic leukaemia extended maintenance chemotherapy has no benefit

1984 • 14 citations

Short‐term remission induction and consolidation therapy for adult acute myelogenous leukemia

1991 • 8 citations

Cited By (0)

No citing papers found in database

Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia (1994) – New England Journal of Medicine | Metascience Observatory Explorer